Literature DB >> 12822609

Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung.

Katsuhiro Nakagawa1, Tsutomu Yasumitu, Kenjirou Fukuhara, Hiroyuki Shiono, Masanori Kikui.   

Abstract

BACKGROUND: We evaluated the prognosis of adenosquamous carcinoma of the lung after lung resection in comparison with other types of carcinoma.
METHODS: We retrospectively reviewed charts of patients who underwent lung resection for lung cancer.
RESULTS: Surgical outcomes for 30 patients with adenosquamous carcinoma of the lung, who were treated between 1976 and 1998, were compared with the surgical results for 1,219 patients similarly treated for adenocarcinoma or squamous cell carcinoma during the same period. Adenosquamous carcinoma comprised only 2.1% of 1,408 lung cancer cases treated by resection. The overall cumulative 5-year survival rate was only 6.2% for the patients with adenosquamous carcinoma, indicating a significantly poorer prognosis than for adenocarcinoma or squamous cell carcinoma.
CONCLUSIONS: The cumulative survival rate for patients with adenosquamous carcinoma in pathologic stages IA to IIB was similar to that of patients with stage IIIA adenocarcinoma or squamous cell carcinoma.

Entities:  

Mesh:

Year:  2003        PMID: 12822609     DOI: 10.1016/s0003-4975(03)00022-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  23 in total

1.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

Review 2.  Lineage factors and differentiation states in lung cancer progression.

Authors:  W K C Cheung; D X Nguyen
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

3.  Ku80 is differentially expressed in human lung carcinomas and upregulated in response to irradiation in mice.

Authors:  Jian Ye; Zhenyi Ren; Qing Gu; Limin Wang; Jiaoli Wang
Journal:  DNA Cell Biol       Date:  2011-06-11       Impact factor: 3.311

4.  Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched Analysis.

Authors:  Shuncang Zhu; Tao Ge; Yicheng Xiong; Jing Zhang; Di Zhu; Liangdong Sun; Nan Song; Peng Zhang
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

5.  Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: risk of coexistent double cancer.

Authors:  Hidetaka Uramoto; Sohsuke Yamada; Takeshi Hanagiri
Journal:  J Cardiothorac Surg       Date:  2010-10-29       Impact factor: 1.637

6.  Clinical characteristics and prognosis of patients with lung adenosquamous carcinoma after surgical resection: results from two institutes.

Authors:  Lewei Zhu; Long Jiang; Jie Yang; Weiquan Gu; Jianxing He
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

7.  Stereotactic aspiration combined with gamma knife radiosurgery for the treatment of cystic brainstem metastasis originating from lung adenosquamous carcinoma: A case report.

Authors:  Chao DU; Zhaohui Li; Zhijia Wang; Liping Wang; Y U Tian
Journal:  Oncol Lett       Date:  2015-02-16       Impact factor: 2.967

8.  Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods.

Authors:  Xiaohua Shi; Huanwen Wu; Junliang Lu; Huanli Duan; Xuguang Liu; Zhiyong Liang
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

9.  Characteristics of lymph node metastasis in resected adenosquamous lung cancer.

Authors:  Min Kong; Jiang Jin; Xiuyu Cai; Jianfei Shen; Dehua Ma; Minhua Ye; Chengchu Zhu; Samuel Freedman; Kelly Walters; Xin Xu; Baofu Chen
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Clinicopathological characteristics and survival outcomes in adenosquamous carcinoma of the lung: a population-based study from the SEER database.

Authors:  Jian Wang; Bi Lian; Ling Ye; Jie Hu; Yuanlin Song
Journal:  Oncotarget       Date:  2017-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.